MTOR and cancer: Chemotherapy-responding TNBC patients revealed upregulated miR-30a (affected transcriptional regulation in cancer) and miR-9-3p (affected mTOR/mammalian target of rapamycin and TGF/transforming growth factor-β signaling) as well as suppressed miR-770-5p (affected B and T cell receptor signaling) and miR-143-5p (affected B and T cell receptor signaling as well as mTOR signaling)[55].